Evaluation of the impact of the diabetes mellitus on endometrial cancer risk- 
an updated meta-analysis of case-control studies

Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst 2017; 110: 354-61.

Google Scholar

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49.

Google Scholar

Gu B, Shang X, Yan M, et al. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019. Gynecol Oncol 2021; 161: 579-80.

Google Scholar

Rodriguez AC, Blanchard Z, Maurer KA, Gertz J. Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions. Horm Cancer 2019; 10: 51-63.

Google Scholar

Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet 2022; 399: 1412-28.

Google Scholar

Wang Y, Zeng X, Tan J, et al. Diabetes mellitus and endometrial carcinoma: risk factors and etiological links. Medicine 2022; 101: e30299.

Google Scholar

Saed L, Varse F, Baradaran HR, et al. The effect of diabetes on the risk of endometrial cancer: an updated a systematic review and meta-analysis. BMC Cancer 2019; 19: 527.

Google Scholar

Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74.

Google Scholar

Wang L, Du ZH, Qiao JM, Gao S. Association between metabolic syndrome and endometrial cancer risk: a systematic review and meta-analysis of observational studies. Aging (Albany NY) 2020; 12: 9825-39.

Google Scholar

10.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.

Google Scholar

11.

Wells G, Shea S, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011 [available: 02/07/2024] https://www.ohri.ca/programs/c....

Google Scholar

12.

George BJ, Aban IE. An application of meta-analysis based on DerSimonian and Laird method. J Nucl Cardiol 2016; 23: 690-2.

Google Scholar

13.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.

Google Scholar

14.

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.

Google Scholar

15.

Esposito G, Bravi F, Serraino D, et al. Diabetes risk reduction diet and endometrial cancer risk. Nutrients 2021; 13: 2630.

Google Scholar

16.

Dossus L, Kouloura E, Biessy C, et al. Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecol Oncol 2021; 162: 475-81.

Google Scholar

17.

Rodriguez AM, Polychronopoulou E, Hsu E, et al. Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics. Gynecol Oncol 2021; 160: 16-23.

Google Scholar

18.

Gao J, Yang G, Wen W, et al. Impact of known risk factors on endometrial cancer burden in Chinese women. Eur J Cancer Prev 2016; 25: 329-34.

Google Scholar

19.

Nagle CM, Marquart L, Bain CJ, et al.; the Australian National Endometrial Cancer Study Group. Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer 2013; 49: 2717-26.

Google Scholar

20.

Torres ML, Weaver AL, Kumar S, et al. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol 2012; 120: 998-1004.

Google Scholar

21.

Fiedenreich C, Biel RK, Lau DCW, et al. Case–control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Epidemiol Biomarkers Prev 2011; 20: 2384-95.

Google Scholar

22.

Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol 2011; 22: 884-9.

Google Scholar

23.

Burbos N, Musonda P, Giarenis I, et al. Predicting the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding: the Norwich DEFAB risk assessment tool. Br J Cancer 2010; 102: 1201-6.

Google Scholar

24.

Zhang Y, Liu Z, Yu X, et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 2010; 117: 41-6.

Google Scholar

25.

Fortuny J, Sima C, Bayuga S, et al. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009; 18: 1448-56.

Google Scholar

26.

Lucenteforte E, Bosetti C, Talamini R, et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 2007; 97: 995-8.

Google Scholar

27.

Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2007; 167: 607-14.

Google Scholar

28.

Strom BL, Schinnar R, Weber AL, et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 2006; 164: 775-86.

Google Scholar

29.

Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol 2006; 35: 151-8.

Google Scholar

30.

Weiss JM, Saltzman BS, Doherty JA, et al. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol 2006; 164: 56-62.

Google Scholar

31.

Xu WH, Matthews CE, Xiang YB, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 2005; 161: 939-47.

Google Scholar

32.

Salazar-Martínez E, Lazcano-Ponce EC, Lira-Lira GG, et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000; 11: 707-11.

Google Scholar

33.

Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185-92.

Google Scholar

34.

Belfiore A, Malaguarnera R, Vella V, et al. Insulin receptor isoforms in physiology and disease: an updated view. Endocr Rev 2017; 38: 379-431.

Google Scholar

35.

Kuryłowicz A. Estrogens in adipose tissue physiology and obesity-related dysfunction. Biomedicines 2023; 11: 690.

Google Scholar

36.

Yuan L, Ni J, Lu W, et al. Association between domain-specific sedentary behaviour and endometrial cancer: a systematic review and meta-analysis. BMJ Open 2023; 13:e069042.

Google Scholar

37.

Teoh SL, Das S. Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. Tumor Biol 2016; 37: 14363-80.

Google Scholar

38.

Morisset AS, Blouin K, Tchernof A. Impact of diet and adiposity on circulating levels of sex hormone-binding globulin and androgens. Nutr Rev 2008; 66: 506-16.

Google Scholar

39.

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.

Google Scholar

40.

Tian J, Liang Y, Qu P. Antidiabetic medications and the risk of endometrial cancer in patients. Gynecol Obstet Invest 2019; 84: 455-62.

Google Scholar

41.

Cicero A F, Tartagni E, Ertek S. Management of diabetic patients with hypoglycemic agents. Metformin and its clinical use: new insights for an old drug in clinical practice. Arch Med Sci 2012; 8: 907-17.

Google Scholar

42.

Meireles CG, Pereira SA, Valadares LP, et al. Effects of metformin on endometrial cancer: systematic review and meta-analysis. Gynecol Oncol 2017; 147: 167-80.

Google Scholar

43.

Clement NS, Oliver TR, Shiwani H, Saner JR, Mulvaney CA, Atiomo W. Metformin for endometrial hyperplasia: a Cochrane protocol. BMJ Open 2016; 6: e013385.

Google Scholar

44.

Yao K, Zheng H, Li T. Association between metformin use and the risk, prognosis of gynecologic cancer. Front Oncol 2022; 12: 942380.

Google Scholar

45.

Soffer D, Shi J, Chung J, et al. Metformin and breast and gynecological cancer risk among women with diabetes. BMJ Open Diabetes Res Care 2015; 3: e000049.

Google Scholar

Submit your paper

eISSN:	1896-9151
ISSN:	1734-1922